conversion from asexual proliferation to sexual differentiation initiates the production of the gametocyte, which is the malaria parasite stage required for human-to-mosquito transmission. this protocol describes an assay designed to probe the effect of drugs or other perturbations on asexual replication, sexual conversion and early gametocyte development in the major human malaria parasite Plasmodium falciparum. synchronized asexually replicating parasites are induced for gametocyte production by the addition of conditioned medium, and they are then exposed to the treatment of interest during sexual commitment or at any subsequent stage of early gametocyte development. Flow cytometry is used to measure asexual proliferation and gametocyte production via Dna dye staining and the gametocyte-specific expression of a fluorescent protein, respectively. this screening approach may be used to identify and evaluate potential transmission-blocking compounds and to further investigate the mechanism of sexual conversion in malaria parasites. the full protocol can be completed in 11 d.
IntroDuctIon
After injection by a mosquito into a human host and a single round of mitotic expansion within hepatocytes, malaria parasites undergo an indefinite number of asexual replication cycles within red blood cells (RBCs) . During each of these intra-erythrocytic developmental cycles (IDCs), a small proportion of parasites stop replicating and initiate development into sexual precursor cells in a process known as sexual conversion. These sexual precursor cells, called gametocytes, are at maturity the only parasite form capable of establishing an infection in the mosquito vector. Sexual conversion and proper gametocyte development are thus essential for transmission of malaria.
Strategies for preventing transmission of parasites from humans to mosquitos are essential for efforts aiming at malaria elimination and eradication 1 . As gametocytes are required for transmission and are produced in low numbers, they represent an important and potentially vulnerable target for transmissionblocking therapies. However, most antimalarial drugs in current use perform poorly at killing mature gametocytes and are thus unable to fully prevent malaria transmission. Some reports have suggested that treatment with antimalarial compounds, such as pyrimethamine [2] [3] [4] , chloroquine 5 and mefloquine 6 , may even increase the number of gametocytes produced in patients or under in vitro conditions, possibly by increasing sexual conversion rates 7 . Similarly, enhancement of gametocyte production and transmission has been observed with drug-resistant parasites in rodent infections 8 . Clearly, there is an important but unmet need for methods for identifying agents that inhibit gametocytes throughout all stages of development. In addition, better methods are required to ensure that future antimalarial drugs do not stimulate gametocyte production.
The assay presented here focuses on P. falciparum, the parasite species responsible for the vast majority of >600,000 malaria deaths each year 9 . The presented protocol allows experimenters to manipulate the rate at which P. falciparum parasites commit to either the asexual or the sexual developmental pathway in a highly targeted and reproducible manner. It describes an updated and streamlined version of our previously developed drug screening assay 10 , which was the first assay capable of targeting both sexual conversion and the earliest stages of gametocyte development. The assay involves the simultaneous measurement of total parasite proliferation and gametocyte production during a single blood-stage replication cycle. We have used variations of this assay to complete dose-response and window-of-action analyses of antimalarial compounds under development 11, 12 . The protocol presented here ( Fig. 1) enables screening of drugs or other perturbations against highly synchronous early gametocytes. It additionally allows experimenters to interrogate the biology of sexual conversion and to test antimalarial compounds under development for potential inhibitory or stimulatory effects on gametocyte production.
Stage conversion and transmission of P. falciparum parasites Recent discoveries have begun to shed light on the mechanisms governing the production of gametocytes in Plasmodium, which show that environmental, genetic and epigenetic factors can drive sexual conversion. For example, recent studies have identified a transcription factor, AP2-G (refs. 13, 14) , as well as the epigenetic factors PfHP1 and PfHDA2 (refs. 15,16) , as regulators of sexual commitment. In addition, it was shown that parasites use microvesicle-mediated cellular communication that seems to modulate the rate at which sexual commitment is initiated 17, 18 . Finally, various cellular components have been reported to be required for sexual conversion, including environmental sensing and signaling molecules 19 (i.e., receptors, kinases and G proteins [20] [21] [22] [23] [24] ), cell cycle control proteins, and cellular stress responses 25, 26 . Through an as-yet-unknown pathway, external stimuli are believed to manipulate cell fate decision during the IDC that precedes gametocyte development. Parasites are hence induced by certain microenvironments to commit to either the sexual or the asexual cell fate 27 , and their progeny will either develop into gametocytes or continue asexual proliferation. Altogether, these data suggest that multiple layers of regulation act in concert in order to induce the production of gametocytes. Interestingly, the protein classes suggested to be involved in P. falciparum sexual conversion include numerous major drug targets in other eukaryotes. Identifying the factors associated with conversion in P. falciparum is therefore likely to uncover promising targets for future transmissionintervention strategies.
Comparison with other published P. falciparum in vitro assay protocols A number of high-throughput-compatible whole-cell assay methods have been developed and applied to the screening of compound libraries against Plasmodium asexual and sexual blood stages, as well as liver-stage parasites. Existing screens to identify compounds with an effect on sexual development generally focus on gametocytes in the second half of the 8-12-d maturation process [28] [29] [30] [31] [32] . For example, Peatey et al. 30 and Sanders et al. 29 recently screened compounds against pure populations of mature sexual-stage parasites by using ATP bioluminescence or the gametocytes' ability to exflagellate, respectively, as a readout. In contrast, D'Alessandro et al. 33 assessed the viability of purified mid-stage gametocytes in a lactate dehydrogenase assay, whereas Lucantoni et al. 34 screened against early-to-mid-stage gametocytes using a luciferase reporter-based system. Screens targeting young gametocytes are largely underrepresented, which is at least partially attributable to the fact that these stages are difficult to separate from the bulk of asexually replicating parasites. As we demonstrate with the assay presented here, flow cytometry combined with an appropriate reporter system can make such screens possible. Other than the presented screen, Wang et al. 35 developed the only cytometry-based approach that enables targeting sexual-stage parasites, including early gametocytes. In that assay, drug susceptibility of developing gametocytes is tested after they have been purified from asexual cells by sequential treatments with sorbitol, Percoll and heparin. Our protocol, by contrast, uses flow cytometric detection of a gametocyte-specific fluorescent reporter to quantify early gametocytes within the asexual population, and thus it avoids the necessity of purifying gametocytes or applying compounds that specifically kill asexual cells. (i) asexual parasite populations containing negligible numbers of gametocytes or (ii) cultures that are greatly enriched in highly synchronous gametocytes-a feature that is unique to this screen. This allows screening for compounds that inhibit sexual conversion and/or development, as well as for conditions that trigger gametocytogenesis. Consequently, diverse questions about drug susceptibility and the biology of sexual differentiation may be addressed using the same basic and simple assay.
Owing to its excellent performance in inducing highly synchronous gametocyte populations, and in contrast with most published screens, the presented assay does not require physical purification of sexual-stage parasites or removal of gametocytes formed during previous IDCs. Further, the effect of the perturbation of interest on asexual parasite proliferation is detected in the same well, making the assay ideal for screens to identify molecules that specifically target gametocytes but not asexual blood stages and vice versa.
Experimental design
In the assay presented here, modified from Buchholz et al. 10 , stage-synchronized blood-stage parasites are seeded in 96-well plates (220 µl per well, 0.3% parasitemia, 2.5% hematocrit (HC)) at 28 ± 4 h post invasion (h.p.i.; IDC-IV; Fig. 1 ). In wells to be stimulated for high gametocyte production, sexual conversion is induced at that time point by the addition of parasite-conditioned medium (CM) for 24 h under well-defined conditions. The CM is produced on a separate parasite culture maintained at high parasitemia (HP; IDC-III; Fig. 1 ).
When screening for inhibitory effects on sexual conversion and/or gametocyte development, the culture is induced by applying CM, and test compounds are simultaneously added to the cells or at any later time point, depending on the experimenter's requirements. When screening for stimulatory effects on sexual conversion, cells are not induced before treatment with test compounds. In a set of control wells, parasites are cultured without drug addition. In the presence of CM, these will produce high proportions of gametocytes, whereas only few gametocytes are formed under noninducing control conditions. After the parasites have re-invaded erythrocytes, flow cytometry is first used to determine parasitemia (IDC-V, 28 ± 4 h.p.i.; Fig. 1 ) and, 38 h later, to evaluate the proportion of early gametocytes (IDC-V, 66 ± 4 h.p.i.; Fig. 1 ) using DNA dye staining and fluorescent protein expression, respectively. The effect of drug treatment on the proportion of parasite offspring that become gametocytes (referred to as the conversion rate), on the overall asexual parasite proliferation rate, and/or on gametocyte survival is determined by comparison with the high-gametocyte and low-gametocyte control wells (see PROCEDURE).
Gametocyte detection relies on the expression of the red fluorescent reporter tandem Tomato (tdTom), which is driven by the promoter of the gametocyte-specific gene etramp10.3 (PF10_0164/PF3D7_1016900) (refs. 10,36,37) . The fluorescence intensity of gametocytes produced in parasite lines carrying this reporter system (termed 164-tdTom) allows for stage-diagnostic signal detection by flow cytometry after 62 h.p.i. At this time point, gametocytes formed during the next IDC are not yet detectable 10 .
As described above, multiple assay setups are available to address different questions. Drugs or other perturbing conditions can be evaluated for negative effects on sexual conversion or early gametocyte development, as well as for effects that potentially induce or enhance the production of gametocytes. As the assay does not require purification of gametocytes, the effect of treatment on asexual parasites can be measured simultaneously, which allows the investigation of differences in drug susceptibility between asexual-and sexual-stage parasites in the same well.
Optimization. On the basis of our published protocol 10 , we have streamlined and updated the assay setup. For simplicity and ease of use with large culture volumes, we replaced the combination of sorbitol and Percoll synchronization steps 10 with a series of four sorbitol treatments (IDC-I through IDC-IV; Fig. 1 ), to generate parasites synchronized to an 8-h age window. The assay presented here is now based on the gametocyte-specific expression of a tdTom reporter. Compared with the former protocol 10 , in which we used GFP fluorescence as a readout, this has significantly improved the signal-to-noise ratio from below 10 to 1,142 ± 186 (values represent the mean ± s.d. of five biological replicates) by avoiding an overlap between the spectrum of our reporter and the autofluorescence of erythrocytes in green wavelengths 38 . Moreover, we found P. falciparum strain Pf2004 to be favorable for the purposes of our assay. In comparison with reference isolates, Pf2004 is a more recently culture-adapted, gametocyte-producing isolate from Ghana 39, 40 . Compared with other laboratory strains such as 3D7 or HB3, the Pf2004/164-tdTom line is more responsive to environmental stimuli that induce sexual conversion (Fig. 2) , whereas the rate at which gametocytes are formed under normal growth conditions (that is, baseline conversion rate) is negligible. The assay thus allows for the controlled production of highly synchronous gametocyte populations that can be perturbed as soon as sexual commitment is initiated.
Although we provide a protocol for the reproducible induction of gametocytogenesis, sexual-stage conversion remains a multilayered process that is sensitive to a variety of both environmental and parasite-intrinsic factors. Consequently, gametocyte conversion rates vary between different inductions, depending on the exact composition of the experimental cell population and the batch of CM used (referred to as an 'induction batch'). However, it is noteworthy that the presented protocol allows for a steady induction of gametocytogenesis. Z′-factors within individual induction batches consistently remain above 0.7 (0.79 ± 0.01, mean ± s.d.; n = 9), indicating that the assay should be adaptable to high-throughput platforms. Z′-factors were calculated according to Zhang et al. 41 , using induced Pf2004/164-tdTom cultures treated with lethal doses of dihydroartemisinin as negative controls and nontreated cells as positive controls. In contrast to other screens, in which the dynamic range of the signal is defined by technical constraints, variability of CM composition is an inherent component of the presented assay, and therefore Z′-factors calculated from across induction batches fail to describe the screens' performance. To prevent false positive and/or negative hits, screening results must thus always be interpreted in relation to 'induced' (that is, treated with CM) and 'noninduced' control conditions from the same induction batch (see PROCEDURE). Compared with the consistently low conversion rates of noninduced populations (0.3 ± 0.06%, mean ± s.d., n = 5), CM-treated Pf2004/164-tdTom cultures produce at least 40 (61.8 ± 17.8, mean ± s.d., n = 5) times more gametocytes, typically converting to the sexual pathway at a rate of 14 to 24% (17.8 ± 5.4%, mean ± s.d., n = 5). This high responsiveness of the Pf2004/ 164-tdTom line to CM treatment is particularly important when screening compounds or growth conditions that induce gametocytogenesis, and it generally allows one to identify hits with high accuracy.
Although we recommend the use of the Pf2004/164-tdTom line, the assay can also be carried out using transgenic 3D7 parasites, as reported in our original screen 10 , or by using HB3 parasites carrying the respective reporter plasmid. However, higher baseline conversion rates of both of these strains compared with Pf2004 may limit the ability to detect perturbations that stimulate sexual conversion. Transgenic 3D7, HB3 and Pf2004 strains can be requested from our laboratory, and they are available with GFP or tdTom reporters under control of the gametocytespecific promoters of PF3D7_1016900, PF3D7_1477300 or PF3D7_1477700. In addition, the assay should be adaptable for screening of nontransgenic parasites using immunolabeling of gametocytes as readout.
Assay variations. The standard assay as provided below is designed to screen compounds for inhibitory effects on gametocyte production and development, as well as on asexual proliferation. The compounds of interest are hence added simultaneously with the gametocyte-inducing CM or at any later time point, depending on the question being asked. Alternatively, using the same assay setup, compounds or changes in culture condition can be probed for a positive effect on the rate at which parasites switch to the sexual pathway. If screening for such gametocyte-enhancing effects is performed, noninduced parasite populations are probed instead, whereas gametocyte-induced cultures serve as a positive control.
The protocol presented here uses CM at a defined working concentration of 90% (vol/vol) to induce gametocytogenesis in P. falciparum. The use of different CM concentrations may increase or decrease gametocyte production while having the inverse effect on asexual replication. Consequently, there is a fine line between optimal induction of gametocytogenesis and provoking parasite death. In our hands, highest sexual conversion rates are obtained with a 90% (vol/vol) CM working solution. Before starting the screen, it may, however, be advisable to test the performance of different CM concentrations. This optional evaluation is performed by following the protocol as described in the PROCEDURE section, and it should include parasites cultured in either malaria culture medium (MCM; negative control) or CM at 90, 92.5 and 95% (vol/vol).
Limitations. We strongly recommend that personnel performing this screen have experience in P. falciparum in vitro culture or are supervised by an expert in the field. As compared with plate reader-based methods, the flow cytometry readout of our assay places a limit on the number of compounds that can be screened per unit of time. Labor is a limiting factor of this assay because of the multiple synchronization and readout steps, as well as the long time span of the full assay (Fig. 1) , and it can be beneficial to have two individuals share steps in the protocol. Because multiple cell cycles are required for sexual conversion and gametocytes require time to develop to a distinguishable stage, assays that screen gametocytes, whether mature or immature, necessarily occur over a longer time span than assays targeting asexual blood stages.
When developing the original assay, we observed highly increased gametocyte levels after treatment with sublethal doses of some antimalarials such as atovaquone and methylene blue 10 . Further investigation of this phenomenon revealed that the cytostatic effect of these drugs results in an immediate but transient 'faux' activation of the fluorescent reporter preceding reporter expression during early gametocyte development. Importantly, owing to the temporal differences in reporter activation, the assay presented here is capable of distinguishing these 'faux-induced' parasites from sexually committed cells (see Supplementary  Fig. 1 and ANTICIPATED RESULTS) . • . We recommend minimizing handling time outside ideal growth conditions (37 °C in gas mixture optimized for malaria culture). After each step involving handling parasites, promptly return the dishes to a culturing chamber and add optimized gas mixture, and then return the chamber to an incubator at 37 °C. Alternatively, return it to a gassed TC incubator system at 37 °C. Per screening plate, start the experiment with ~10 ml of culture at a ring-stage parasitemia of at least 2%. To evaluate parasitemia (percentage of parasite-infected RBCs), place 2 µl of packed RBCs on a glass slide and use the edge of another glass slide to smear. Stain using Diff-Quik or another staining system. Count infected cells per 2,000 total RBCs using a light microscope. ! cautIon P. falciparum is a human pathogen; consult local regulations for handling and waste disposal requirements. Wear gloves and a lab coat.  crItIcal To maintain sterility of cells, all steps involving cells that will be returned to culture, as well as culture reagent preparation, must be carried out under sterile conditions in a biosafety cabinet.  crItIcal P. falciparum lines can lose the ability to produce gametocytes after extended in vitro culturing 43 . Keep multiple aliquots of the original parasite stabile in liquid nitrogen, and maintain gametocyte-producing cultures at a low passage number. Incomplete malaria culture medium In a clean and sterile flask, prepare 4 liters of medium as follows: dissolve 41.76 g of RPMI powder with phenol red and 23.76 g of HEPES (free acid) in 2.8 liters of ddH 2 O and stir it for at least 30 min. Separately, add 400 mg of hypoxanthine to 80 ml of boiling water and mix to dissolve. Add 40 ml of the hypoxanthine and 1 liter of ddH 2 O to the 4-liter flask. Use a pH meter to adjust the pH to exactly 6.75 with 1 M NaOH. Filter-sterilize the solution by passing it through a filter with a 0.22-µm pore size in a tissue culture hood, and then store it at 4 °C for up to 4 weeks. Complete malaria culture medium Dissolve NaHCO 3 to 3.6% (wt/vol) in water and filter-sterilize it. To 210 ml of incomplete MCM, add 14 ml of NaHCO 3 solution and 25 ml of human serum under sterile conditions. Mix the medium and store it at 4 °C for up to 2 weeks. 5% (wt/vol) sorbitol Prepare 5% sorbitol (wt/vol) in dH 2 O. Filter-sterilize the solution by passing it through a 0.22-µm filter in a tissue culture hood, and store it at 4 °C for up to 6 months. Sorbitol treatment lyses erythrocytes infected with 24-to 48-h-old P. falciparum cells, and thus it synchronizes the parasites to 24 h.p.i. and younger. SYBR Green staining solution Prepare SYBR Green staining solution immediately before use by diluting SYBR Green stock solution to a 1:5,000 ratio in PBS. WR 99210 Completely dissolve WR 99210 to 2 mM in 10 ml of RPMI-HEPES in a 15-ml Falcon tube by rotating it for 1-3 h. Filter-sterilize and store this stock solution at −20 °C for at least 5 years. To prepare working solution, dilute the stock to a 1:200 (to 10 µM) ratio in RPMI-HEPES and store it at 4 °C for up to 4 weeks. Add 4 µl of working solution per 10 ml of parasite culture. If an alternative flow cytometer is used, the specific settings may need to be optimized to ensure good separation between the uninfected RBC, asexual parasite and gametocyte populations. 
IDc-II: preparation of experimental cells and cultures producing the cM • tIMInG 30 min 6|
Evaluate parasitemia by light microscopy using Diff-Quik-or Giemsa-stained blood smears. Perform this step and Steps 7 and 8 after parasite reinvasion is completed (i.e., 40-48 h after Step 5).  crItIcal step A minimum of 2% parasitemia is required. ? trouBlesHootInG 7| Prepare a low-parasitemia (LP) culture by splitting the synchronous parasite population into a new dish at parasitemia of ~0.3%, while maintaining the HC at 5%. In this LP culture, the proportion of infected cells will be kept below 1% to prevent stress responses that may lead to a premature induction of gametocytogenesis.  crItIcal step This culture will provide the experimental cells, used in Steps 15 and 16.
8| Prepare a second culture with a parasitemia of 1.5-2% (HP) and expand the culture volume according to your requirements (220 µl of CM is needed per well of a 96-well plate; save an additional 110 µl per well for the washing procedure given in Steps 15 and 16).  crItIcal step The HP culture is used for the preparation of CM, as described in Steps 10-12. 15| At 28 ± 4 h.p.i., prepare cells to be treated with drugs (and untreated positive-control cells) by inducing gametocytogenesis as follows: pellet the required volume of the LP culture (calculate the volume on the basis that 110 µl is needed per well of a 96-well plate; e.g., 6.6 ml for 60 wells). Wash it once in an equal volume (e.g., 6.6 ml for 60 wells) of CM working solution. Resuspend the cells in twice the volume (e.g., 13.2 ml for 60 wells) of CM working solution.
16| Also prepare cells to be used as 'noninduced' negative controls by pelleting the required amount (110 µl is needed per well of a 96-well plate) of the LP culture in a conical centrifuge tube and by washing the cells in an equal volume of prewarmed MCM. Resuspend the cells in twice the volume of MCM.  crItIcal step If drugs are screened for effects that induce sexual conversion, prepare nontreated control cells as described in Step 15 rather than as described in this step, as the conditions described in Step 15 will control for maximal induction of sexual conversion. In this situation, prepare the experimental cells to be treated, as described in this step (Step 16).
17|
Distribute 220 µl of cell suspension per well of a 96-well plate. Note that the parasite culture now contains 0.3% infected erythrocytes at an HC of 2.5%. Fill unused surrounding wells with incomplete medium to prevent evaporation.
18|
Add the compounds of interest now (when parasites are at 28 ± 4 h.p.i.) or during Step 20 (IDC-V, 8 ± 4 h.p.i.) and mix by pipetting up and down. Note that administering compounds during IDC-V will probe for effects on early gametocyte development, whereas compounds added during the present cycle (IDC-IV) will also test for potential effects on sexual conversion. Include untreated control wells in every plate. Do not add drug to these wells, but do include the maximum concentration of the compound vehicle (for example, DMSO) used in the experiment.  crItIcal step Changes in culture volume may affect gametocyte conversion rate. We thus recommend adding relatively low and equal volumes (2-10 µl) of compound stock solutions to each well. We observed that DMSO concentrations of up to 0.3% do not affect parasite growth or gametocyte production or development; nevertheless, DMSO-alone controls should be included.  crItIcal step Perturbations of interest can be introduced at time points other than those indicated. Any time point between 28 ± 4 h.p.i. of IDC-IV and 36 ± 4 h.p.i. of IDC-V may be chosen to answer more specific questions about sexual commitment or early gametocyte development. 20| 
IDc
Add compounds to be tested for effects on early gametocyte development when parasites are at 8 ± 4 h.p.i.
23|
Run flow cytometry to determine parasitemia. Measure 100,000 events per well. See Equipment Setup for optimized flow cytometry settings. Parasite multiplication rate of CM-treated cultures typically drops by two-to threefold compared with parasites grown under noninducing conditions. This is indicative for a successful induction of gametocyte production. Owing to the low starting parasitemia, parasite multiplication rates are not restricted by self-induced nutrient depletion, and noninduced parasite cultures are expected to reach a parasitemia of 2.1-2.7% in IDC-V, whereas CM-induced cultures typically grow to a parasitemia of 0.6-0.9%. During subsequent IDCs, however, asexual parasite growth will be hampered owing to high parasite densities. Although this has no effect on gametocyte development, asexual parasite growth rates should thus not be used as a basis for analyses after this time point. Conversion rates will be calculated as a proportion of gametocytes formed from the pool of parasites determined in this step. Therefore, asexual replication can be ignored after IDC-V. 
25|
Perform flow cytometry to determine gametocytemia. Measure 400,000 events per well. See Equipment Setup for optimized flow cytometry settings.  crItIcal step Although setting up this cytometric readout is not labor-intensive, enough time should be scheduled to allow detection of 400,000 events per well (usually 1-2 min are required per well, depending on the equipment and settings used). ? trouBlesHootInG  pause poInt Data analysis (next section) can be performed at any time point after data acquisition.
Flow cytometry data analysis and hit selection • tIMInG 1.5 h  crItIcal Data analysis can be carried out using any cytometry analysis program (e.g., FlowJo).
26|
To visualize flow cytometry data, export .fcs data files from the flow cytometer to the cytometry analysis program. Generate dot plots with Y2 intensity (tdTom fluorescence) on the y axis and B1 intensity (SYBR Green fluorescence) on the x axis. Gate double-negative uninfected RBC (uRBC), SYBR Green-positive (asexual parasite) and tdTom/SYBR double-positive (gametocyte) cell populations (Fig. 2b) . Use the same gates for all samples from the same flow cytometry run. The gates should be drawn on the basis of scatterplots from induced untreated control samples (Fig. 2b) .  crItIcal step Although the cell populations separate clearly, caution is required when gating the tdTom/SYBR doublepositive gametocytes. After defining the gate, it should be applied to noninduced control samples to test for an overlap with the asexual (tdTom negative) population. In case such an overlap is observed, the lower gate boundaries have to be shifted toward higher tdTom intensities. While reducing the number of false positive counts, which is essential for the performance of the assay, this procedure may result in the loss of some gametocytes with low tdTom expression. If the asexual and sexual populations are not separating clearly, it is advisable to perform the flow cytometry readout at a later time point (compare Step 24) . 
29|
Calculate the mean rate of sexual conversion or gametocyte survival ± s.d. for all test conditions, as well as for the induced, noninduced and vehicle controls.  crItIcal step Confirm the absence of marked effects of the vehicle on parasitemia, gametocytemia and conversion rate by comparing the vehicle-only controls with induced and noninduced control samples.
30|
Assess the effect of probed perturbations on sexual conversion and/or gametocyte survival in relation to the induced control wells created in Step 15 (defining maximal sexual conversion and 100% gametocyte survival, respectively) and noninduced control wells created in Step 16 (defining baseline conversion).
Perturbation effect conversion rate convers tested perturbation = i ion rate control E.g: the tested compound is administered under gametocyte-inducing conditions, and it results in a conversion rate of 5% (determined in Step 28), whereas the induced control population produces 20% gametocytes. In this example, the tested compound reduces gametocyte production by 75% down to 25% (5%/20% = 0.25).
31| Identify 'hits' according to self-determined thresholds.
? trouBlesHootInG Troubleshooting advice can be found in table 1. Figure 2 . In the case of low gametocyte production, increase the concentration of the CM working solution (e.g., from 90% to 95%). Alternatively, increase the parasitemia of the culture used to produce the CM (see Step 10 
antIcIpateD results
The protocol presented here is designed to probe the effect of drugs and other changes in culture conditions on asexual parasite replication and early sexual development. Gametocytes are detected using the stage-specific expression of a fluorescent reporter. This renders the assay independent from gametocyte purification steps, and it enables screening the effects of perturbations on the earliest phases of gametocyte development including sexual commitment. Tightly synchronized parasites of the Pf2004/164-tdTom cell line (others are available, see MATERIALS) are induced for gametocytogenesis by applying a standardized CM working solution. In contrast to other protocols, the induced culture is kept at a low starting parasitemia of 0.3% in this assay. Therefore, culture conditions are only marginally influenced by the parasite population itself, which allows for a standardized and highly reproducible induction process. Whereas parasites cultured under noninducing conditions typically multiply by a factor of 7-9, the addition of CM is expected to reduce PEMR to 2-3, resulting in a parasitemia of 2.1-2.7% and 0.6-0.9%, respectively, during the following cycle. As early as 62 h.p.i., gametocytes expressing the red fluorescent reporter tdTom can be quantified by flow cytometry. Compared with noninduced cultures, CM-treated parasite populations are expected to increase sexual conversion rates by 40-to 80-fold from ~0.3% to 14-24% (Fig. 2) . Consequently, 350-900 tdTom-positive cells can be expected under induced and nontreated conditions when counting 400,000 erythrocytes. In contrast, baseline conversion of the noninduced cells will give rise to only 10-30 gametocytes per 400,000 RBCs.
Gametocyte development may be perturbed by introducing the compound of interest at any time during early maturation or even before sexual commitment. For example, dose response to drugs can be measured after administering the compounds at 28 ± 4 h.p.i. (Fig. 3) . At this time point, notably, sexually committed cells cannot yet be physically separated from asexually replicating parasites. In addition, because the assay does not require gametocytes to be purified, the effect of drug treatment on asexual parasites can be monitored simultaneously in the same well. Further, the low rate at which gametocytes are produced in Pf2004/164-tdTom cells under noninducing conditions (Fig. 2a) allows the identification of drugs and other perturbations that induce sexual conversion.
It is worth mentioning that some cytostatic drugs (including methylene blue and atovaquone) seem to deregulate stage-specific expression of gametocyte genes 44 or to induce reporter expression in cells that are not committed to the sexual pathway 10 . This 'faux' induction is transient, initiated at an earlier-than-expected time point and only occurs at drug concentrations causing a near-complete block in asexual parasite replication (supplementary Fig. 1 ). If such 'faux' induction is encountered (see Step 23 of the PROCEDURE), we recommend deferring gametocyte quantification to 90 ± 4 h.p.i. (see Step 24) . At this time point, 'faux'-induced cells have lost tdTom expression. . Shown is the effect of DHA on asexual parasite multiplication (left) and early gametocyte development (right). Mitotic proliferation and gametocyte survival was monitored 48 h after administering DHA at 28 ± 4 h.p.i. Note that both cell lines reveal similar dose-response curves. Curves were generated using a four-parameter nonlinear regression fit. The presented data exemplifies the outcome of a single screening run (mean ± s.e.m., n = 3), as described. Specific doseresponse information gained by using the presented assay is available from Buchholz et al. 10 .
